Aidoc
AI
Aidoc develops AI software for radiology that analyzes medical images and flags suspected urgent conditions. Its algorithms support triage and notification for findings such as stroke, pulmonary embolism, intracranial hemorrhage, and fractures. The tools integrate into imaging workflows to help clinicians review time sensitive cases sooner.
Founded by Gal Yaniv (Founder)
Blended valuation$1.7B
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$6B
blended valuationfunding round
May 31, 2021$0Oct 5, 2026
All rounds
11 funding rounds, newest first.
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series E | Apr 29, 2026 | $150M | $1.7B |
| Round | Jul 23, 2025 | $110M | $1.4B |
| Round | Nov 1, 2023 | $30M | $550M |
| Series D | Jun 16, 2022 | $110M | $906.4M |
| Series C | Jul 13, 2021 | $66M | $501.8M |
Join Legion to view all 11 rounds.Sign in to Legion
Investors
19 investors across all rounds.
- MVMagma Venture Partners
- SPSquare Peg Capital
- GCGeneral Catalyst
- TCTCV
- TPTLV Partners
- EVEmerge Ventures
- GSGoldman Sachs
- NVNVIDIA
- GSGoldman Sachs Alternatives
- SISoftBank Investment Advisers
Only Legion members can view the full investor roster. Sign in to Legion
Secondary market activity
Recent buy and sell interest for Aidoc shares on the secondary market.
| Kind | Implied valuation | Price / share | Date |
|---|---|---|---|
| $4.5B | $27.20 | Jun 23, 2026 | |
| $4.5B | $27.27 | Jun 15, 2026 | |
| $5.2B | $31.39 | May 28, 2026 |
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 14, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.